NEW YORK — BioLabs@NYU Langone, the life-science incubator affiliated with NYU Langone Health, has signed a 46,000-square-foot lease at Innolabs, a purpose-built research facility in Long Island City developed by King Street Properties and GFP Real Estate. The move will shift the incubator from its current Varick Street location in Manhattan to a larger, newly built space designed to support early-stage biotech companies.
BioLabs, based in Boston, operates what it describes as the largest global network of co-working laboratory facilities, with locations in the U.S., Europe, and Japan. Its facilities are structured to provide seed- and early-stage biotechnology companies with turnkey wet-lab space, shared equipment, and programming that connects founders with investors, partners, and peer companies.
“We are proud to support NYU Langone and BioLabs in their mission to nurture groundbreaking companies at the earliest stages,” said Ed Jaram, of King Street Properties. “This addition reinforces Innolabs as a destination in New York City for life-sciences companies.”
NYU Langone said the relocation will help accelerate its efforts to grow the city’s commercial life-science sector and support spinouts emerging from its research programs. “This new space will offer startups … expanded access to the resources, community and infrastructure they need to drive innovation,” said Vicki Match Suna, AIA, executive vice president and vice dean for real estate development and facilities at NYU Langone.
BioLabs CEO and founder Johannes Fruehauf said the new site will build on the incubator’s collaboration with NYU Langone. “BioLabs@NYU Langone will play a pivotal role in the Innolabs ecosystem, fueling and supporting discovery, innovation, and economic growth for the city,” he said.
The 267,000-square-foot Innolabs property includes research and office space along with a café, event space, bike storage, and locker rooms. GFP Real Estate co-CEO Brian Steinwurtzel said the addition of BioLabs strengthens Innolabs’ position as a home for early-stage companies: “This new incubator will continue to foster innovation … and reinforce New York City’s position as a leading hub for life sciences.”
The new BioLabs@NYU Langone facility is now open to early-stage biotechnology firms.
